Seite - (000272) - in Biomedical Chemistry: Current Trends and Developments

Vig, B. S.; Huttunen, K. M.; Laine, K.; Rautio, J. (2013). Amino acids as promoieties in prodrug design and development. Advanced Drug Delivery Reviews, 65, 1370-1385. Vlieghe, P.; Lisowski, V.; Martinez, J.; Khrestchatisky, M. (2010). Synthetic therapeutic peptides: science and market. Drug Discovery Today, 15, 40-56. Walker, I.; Nicholls, D.; Irwin, W. J.; Freeman, S. (1994). Drug delivery via active transport at the blood-brain barrier: affinity of a prodrug of phosphonoformate for the large amino acid transporter. International Journal of Pharmaceutics, 104, 157-167. Wang, Y.; Welty, D. F. (1996). The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysis-pharmacokinetic approach. Pharmaceutical Research, 13, 398-403. Wang, Z.; Wang, G. (2004). APD: The antimicrobial peptide database. Nucleic Acids Research, 32, D520-D592. Wang, G.; Li, X.; Wang, Z. (2009). APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Research, 37, D933-D937. Wei, Y.; Pei, D. (2000). Activation of antibacterial prodrugs by peptide deformylase. Bioorganic and Medicinal Chemistry Letter, 10, 1073-1076. Wimley, W. C.; Selsted, M. E.; White, S. H. (1994). Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Science, 3, 136-1373. Wipf, P.; Li, W. L.; Adeyeye, C. M.; Rusnak, J. M.; Lazo, J. S. (1996). Synthesis of chemoreversible prodrugs of ara-C with variable time-release profiles. Biological evaluation of their apoptotic activity. Bioorganic and Medicinal Chemistry, 4, 1585-1596. Witt, K. A.; Gillespie, T. J.; Huber, J. D.; Egleton, R. D.; Davis, T. P. (2001). Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. Peptides, 22, 2239-2243. Witt, K. A.; Davis, T. P. (2006). CNS drug delivery: Opioid peptides and the blood-brain barrier. AAPS Journal, 8, E76-E88. Wojtowicz, A. M.; Shekaran, A.; Oest, M. E.; Dupont, K. M.; Templeman, K. L.; Hutmacher, D. W.; Guldberg, R. E.; García, A. J. (2010). Coating of biomaterial scaffolds with the collagen- mimetic peptide GFOGER for bone defect repair. Biomaterials, 31, 2574-2582. Woodley, J. F. (1994). Enzymatic barrier for GI peptide and protein delivery. Critical Review in Therapeutic Drug Carrier Systems, 11, 61-95. Wu, G. (2009). Amino acids: metabolism, functions, and nutrition. Amino Acids, 37, 1-17. Wu, J. Y.; Prentice, H. (2010). Role of taurine in the central nervous system. Journal of Biomedical Sciences, 17, S1. Yang, L.; Harroun, T. A.; Weiss, T. M.; Ding L.; Huang, H. W. (2001). Barrel-stave model or toroidal model? A case study on melittin pores. Biophysical Journal, 81, 1475-1485. Yeaman, M. R.; Yount, N. Y. (2003). Mechanisms of antimicrobial peptide action and resistance. Pharmacology Reviews, 55, 27-55. Yi, H. Y.; Chowdhury, M.; Huang, Y. D.; Yu, X. Q. (2014). Insect antimicrobial peptides and their applications. Applied Microbiology Biotechnology, 98, 5807-5822. Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proceedings of the National Academy of Sciences of USA, 84, 5449-5453.